Lei Zhixin, Liu Qianying, Zhu Qianqian, Yang Bing, Khaliq Haseeb, Sun Ao, Qi Yi, Moku Gopi Krishna, Su Yafan, Wang Jiawei, Cao Jiyue, He Qigai
State Key Laboratory of Agriculture Microbiology, College of Veterinary Medicine, Huazhong Agriculture University, Wuhan, China.
Department of Veterinary Pharmacology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Front Chem. 2018 Jun 25;6:244. doi: 10.3389/fchem.2018.00244. eCollection 2018.
Antimicrobial peptide (Piscidin-1) is an effective natural polypeptide, which has great influence and potential on porcine epidemic diarrhea virus (PEDV) and pseudorabies virus (PRV). As an alternative antibiotic substitute, Piscidin-1 was subjected for pharmacokinetics study with three administration routes (i.v, i.m, and p.o) after a single dose of 2 mg/kg in rats and preliminary pharmacodynamics including antiviral activity in cell against PEDV and PRV. Based on 50 percent tissue culture infective dose (TCID), there were about 2 and 10% virus survived ratios for Piscidin-1 against PRV and PEDV, respectively. The plaque test showed 1 and 2 μg/ml Piscidin-1 could eliminate 95% PRV and 85% PEDV, respectively. The main pharmacokinetics parameters of C, AUC, Ke, t, T, MRT, and Cl in plasma were not applicable value, 25.9 μh/ml, 0.041 h, 16.97 h, not available value, 22.77 h, 0.067 L/hkg after i.v administration, 2.37 μg/ml, 18.95 μh/ml, 0.029 h, 23.50 h, 0.33 h, 30.12 h, 0.095 L/hkg after i.m administration and 0.73 μg/ml, 9.63 μh/ml, 0.036 h, 19.46 h, 0.50 h, 26.76 h, 0.171 L/hkg after p.o administration. The bioavailability values after i.m and p.o administrations were calculated as 73.17 and 37.18%, respectively. The i.m administration was selected for pharmacokinetics study in ileum content against PEDV. The main pharmacokinetic parameters of C, AUC, Ke, t, T, MRT, and Cl in ileum content were 1.67 μg/ml, 78.40 μh/ml, 0.034 h, 20.16 h, 8.12 h, 36.45 h, 0.026 L/hkg. The C values in plasma (2.37 μg/ml) and ileum content (1.67 μg/ml) were higher than the effective inhibitory concentration determined in the plaque test, and this indicates that Piscidin-1 might have effective inhibition effect against PRV and PEDV after administration of 2 mg/kg i.m. The results of this study represent the first investigations toward the pharmacokinetic characteristics of piscidin-1 in plasma upon three different administration routes, among which i.m. resulted in the highest bioavailability (73.17%). Furthermore, the pharmacokinetics study of ileum content indicated Piscidin-1 might have good effect against PEDV and could be regarded as an alternative antibiotic in clinical veterinary in the future study.
抗菌肽(Piscidin-1)是一种有效的天然多肽,对猪流行性腹泻病毒(PEDV)和伪狂犬病病毒(PRV)具有重大影响和潜力。作为一种替代抗生素,在大鼠单次给予2 mg/kg剂量后,通过三种给药途径(静脉注射、肌肉注射和口服)对Piscidin-1进行了药代动力学研究,并进行了初步药效学研究,包括其在细胞内对PEDV和PRV的抗病毒活性。基于50%组织培养感染剂量(TCID),Piscidin-1对PRV和PEDV的病毒存活比例分别约为2%和10%。空斑试验表明,1和2 μg/ml的Piscidin-1分别可消除95%的PRV和85%的PEDV。静脉注射后,血浆中C、AUC、Ke、t、T、MRT和Cl的主要药代动力学参数分别为无适用值、25.9 μh/ml、0.041 h、16.97 h、无可用值、22.77 h、0.067 L/hkg;肌肉注射后分别为2.37 μg/ml、18.95 μh/ml、0.029 h、23.50 h、0.33 h、30.12 h、0.095 L/hkg;口服后分别为0.73 μg/ml、9.63 μh/ml、0.036 h、19.46 h、0.50 h、26.76 h、0.171 L/hkg。肌肉注射和口服后的生物利用度值分别计算为73.